SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing surveillance, emphasizing the importance of reporting unexpected adverse events to ...

The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

USF medical engineering professors Dr. Richard Heller and Dr. Mark Jaroszeski have spent more than three decades developing a targeted cancer-treatment technology that avoids traditional chemotherapy ...